The Top Myths About Ketosis Debunked by Clinical Trials
FINAL_PITCH
1. G3 HEALTH
Keep Track of Your Life With
Simplifying treatment and providing ease in
the lives of Type 2 Diabetes patients
6 August 2014
G3 HEALTH
2. G3 HEALTH
Mission: To provide creative solutions to simplify and empower
a healthy way of living
3. G3 HEALTH
Mission: To provide creative solutions to simplify and empower
a healthy way of living
We will collaborate with you to demonstrate the ease of
making healthy decisions about Type 2 Diabetes (T2D)
Brand Promise:
4. G3 HEALTH
Mission: To provide creative solutions to simplify and empower
a healthy way of living
We will collaborate with you to demonstrate the ease of
making healthy decisions about Type 2 Diabetes (T2D)
Brand Promise:
- Exemplify ease through simple, aesthetic design
- Enable active roles in health
- Obtain successful results through partnership
What We Do:
5. G3 HEALTH
Mission: To provide creative solutions to simplify and empower
a healthy way of living
We will collaborate with you to demonstrate the ease of
making healthy decisions about Type 2 Diabetes (T2D)
Brand Promise:
- Exemplify ease through simple, aesthetic design
- Enable active roles in health
- Obtain successful results through partnership
What We Do:
- No one should feel as though they are at a disadvantage
living with T2D
- Knowing that there are alternative options for treating T2D is
essential
- Being aware of certain options means choosing the right
treatment to fit any individual lifestyle
- Simpler regimens encourage effective action in one’s health
- T2D does not define or restrict any one individual
What We Believe:
6. G3 HEALTH
Ted Czyzewski
User Experience/Creative
Razorfish Healthware
University of the Arts ‘14
Midoriko grace Abe
Art Direction
Saatchi & Saatchi Wellness
Brown University ‘15
Brooke Schwartz
University of Florida ‘15
Strategy
Heartbeat Ideas
Avi bronstein
Account Planning
Digitas Health LifeBrands
Johns Hopkins University ‘15
Francesca Carey
Account Management
Digitas Health LifeBrands
Temple University ‘16
Innovative and analytic individuals
dedicated to improving people’s lives
Who We Are
11. G3 HEALTH
Type 2 Diabetes Overview
- Diabetes mellitus Type 2 Definition: hyperglycemia in the context of
insulin resistance and lack of insulin
- T2D overtime from lifestyle practices mainly related to diet and exercise,
but other causes include:
Old age, obesity, heredity, impaired glucose metabolism,
physical inactivity, and race/ethnicity
13. G3 HEALTH
About 29.1
million people
have diabetes
About 1 in
every 11 people
Today, about 1
in every 3 people
will get diabetes
Risk of death
in adults is 50%
higher than for
adults without
diabetes
1 out of 4
don’t know they
have it
Source: http://www.cdc.gov/diabetes/pubs/statsreport14.htm
15. G3 HEALTH
Type 2 Diabetes Management
- These patients face daily challenges of managing their condition
- The Feedback loop of the glucose cycle gives rise to many complexities
- Patients are responsible for the controlling of risk factors that may
lead to secondary conditions
17. G3 HEALTH
Our Type 2 Diabetes Patient
- 20 to 48 year olds who live an on-the-go lifestyle
- Gfk Roper Diabetes study:
39% of Gen. x and Y adults with T2D have Ac1 levels of 7 or above--
“worry zone for blood sugar”
- T2D patients think they can get by without taking medication
18. G3 HEALTH
Source: 2009–2012 National Health and Nutrition Examination Survey estimates applied to 2012 U.S. Census data.
Diagnosed and Undiagnosed Diabetes
in People 20+ in the U.S.
20. G3 HEALTH
Type 2 Diabetes Patient Interview
- Patient: Tim Keenan, a 45 year old Baltimorean with Type 2 Diabetes
- How he approaches his Type 2 Diabetes:
Disciplined and successful management despite psychological
shock and multiple disease-related fears
- He embodies how we strive to help everyone with diabetes become
25. G3 HEALTH
- Once-daily oral medication for the treatment of type 2 diabetes
- An investigational sodium-dependent glucose co-transporter-2
(SGLT-2) inhibitor, representing a new mechanism of action (MoA)
- Effective both alone and as an add-on therapy with clinical results
that show improvements in glycemic control and body weight in
adults with T2D
28. G3 HEALTH
Top Competitors on the Market
- FARXIGA is a prescription medicine
used along with diet and exercise
to lower blood sugar in adults with
Type 2 Diabetes.
- In clinical trials, FARXIGA
REMOVED Glucose, REDUCED
A1c with additional weight &
BP* benefits.
*Blood pressure benefits were seen when
used in combination with metformin.
29. G3 HEALTH
Top Competitors on the Market
- FARXIGA is a prescription medicine
used along with diet and exercise
to lower blood sugar in adults with
Type 2 Diabetes.
- In clinical trials, FARXIGA
REMOVED Glucose, REDUCED
A1c with additional weight &
BP* benefits.
*Blood pressure benefits were seen when
used in combination with metformin.
- In clinical studies of about 10,000
patients, INVOKANA® demonstrated
significant blood sugar reductions.
- Adults with type 2 diabetes can lose
some weight and may see their
systolic blood pressure lowered.
- INVOKANA® works with your
kidneys to help you lose some sugar
through the process of urination.
31. G3 HEALTH
Incretin-based therapies (DPP4s, GLP1s)
- Inhibit the breakdown of GLP1 in the stomach, slowing down glucose
absorption into the bloodstream
- DPP4s are administered orally
- GLP1s are administered via injection
- Note: PHCGflozin can be safely combined with incretin-based therapies,
its main extra-class competition
33. G3 HEALTH
We wish to offer a convenient, easy, pain-free solution
to help patients keep their lives on track, unaffected by
their Type 2 Diabetes management
Based on Our Findings
37. G3 HEALTH
The Reality
Americans cherish a way
of life that creates high
diabetes risk. They do not
like giving any of it up.
Everything about diabetes
is everywhere, giving us
strategic opportunity to go
anywhere.
We’re different not only because
we achieve the same efficacy
with a better safety profile, but
because we focus on getting
patients’ lives on track, not just
their diabetes management.
We’re last to class, but sec-
ond to campaign and first
to talk about patients’ lives,
which leads us to…..
38. G3 HEALTH
People do not want their ways of living to be hindered
by anything. They want to carry on with their routines and
aspirations. They want to remain on track.
Human Reality
